Ress Life Investments A/S
Ress Life Investments A/S publishes Net Asset Value (NAV).
Ress Life Investments A/S publishes Net Asset Value (NAV).
Ress Life Investments
Nybrogade 12
DK-1203 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 2 June 2025
Corporate Announcement 20/2025
Ress Life Investments A/S publishes Net Asset Value (NAV).
Ress Life Investments A/S publishes the Net Asset Value (NAV) per share as of 15 May 2025.
NAV per share in USD: 2614.46
The performance during the first half of May is -0.10% in USD. The year-to-date net performance is 0.74 % in USD.
Assets under management (AUM) are USD 260.1 million.
The NAV per share in EUR is published on the website of Nasdaq Copenhagen under the section AIF Companies and Funds, where the bid and ask prices are published. The daily NAV in EUR is calculated as the most recently published NAV in USD divided by the European Central Bank’s EUR/USD reference rate on the relevant day.
Questions related to this announcement can be made to the company's AIF-manager, Resscapital AB.
Contact person:
Gustaf Hagerud
gustaf.hagerud@resscapital.com
Tel + 46 8 545 282 27
Note: The terms for subscription of shares, minimum subscription amount and redemption of shares are provided in the Articles of Association, Information Brochure and in the Key Information Document available on the Company's website, www.resslifeinvestments.com.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Spar Nord Bank A/S6.6.2025 10:31:01 CEST | Press release
Updated financial Calendar for 2025
Spar Nord Bank A/S6.6.2025 10:31:01 CEST | Pressemeddelelse
Opdateret finanskalender 2025
Vivoryon Therapeutics N.V.6.6.2025 09:45:00 CEST | Press release
Vivoryon Therapeutics N.V. Presents Meta-analysis Data of VIVIAD and VIVA-MIND studies at ERA 2025
OBI Pharma Inc.6.6.2025 09:00:00 CEST | Press release
OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies
Tenneco6.6.2025 09:00:00 CEST | Press release
DRiV Introduces Walker® OE-Quality Starters, Alternators and Air Conditioning Parts – All Backed by 3-Year Warranty
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom